Ivonescimab
UC-GIG-2404 - PRODIGE 110
Phase 2 small_molecule active
Quick answer
Ivonescimab for Biliary Tract Cancer is a Phase 2 program (small_molecule) at Summit Therapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Summit Therapeutics
- Indication
- Biliary Tract Cancer
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active